Oral Session 2-13D MDS：Basic (3)

[OS2-13D-2] Impact of germline variants on myeloid neoplasms and clonal hematopoiesis in Japan

Hideki Makishima¹, Tetsuichi Yoshizato¹, June Takeda¹, Yukihide Momozawa², Yasuhito Nanya¹, Yoshiko Atsuta^3,4, Yusuke Shiozawa^1,5, Yuka Iijima⁶, Kenichi Yoshida¹, Yuichi Shiraishi⁷, Hiromichi Suzuki¹, Yasunobu Nagata¹, Yusuke Sato¹, Nobuyuki Kakiuchi¹, Makoto Onizuka⁸, Keisuke Kataoka¹, Kenichi Chiba⁷, Hiroko Tanaka⁷, Hiroo Ueno¹, Masahiro Nakagawa¹, Hidehiro Itonaga⁹, Yoshinobu Kanda¹⁰, Yasushi Miyazaki⁹, Keizo Horibe⁶, Masashi Sanada⁶, Yoichiro Kamatani², Michiaki Kubo², Satoru Miyano⁷, Seishi Ogawa¹ (1.Pathol. & Tumor Biol., Kyoto Univ., Kyoto, Japan, 2.RIKEN, Yokohama, Japan, 3.Healthcare Administration, Nagoya Univ., Nagoya, Japan, 4.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 5.Pediatrics, Tokyo Univ., Nagoya, Japan, 6.Nagoya Medical Center, Nagoya, Japan, 7.Institute of Medical Science, Tokyo Univ., Tokyo, Japan, 8.Hematol. & Oncol., Tokai Univ., Isehara, Japan, 9.Nagasaki Univ., Nagasaki, Japan, 10.Jichi Medical Univ. Saitama Medical Center, Saitama, Japan)